The largest holder of CVS Health stock is BlackRock Advisors LLC, with 86.2 million shares (6.75% of the company), worth about $8.09 billion as of September 25, 2026. The 10 largest holders together own 39.1%.
In Q2 2026, 2,188 institutional holdings reports listed 1.33 billion shares worth $121.00 billion, up 19.8% in shares from Q1 2026.
Insiders reported 66 transactions in the last two years: 5 sales worth $578.43 million and 3 purchases. The newest one on file is from May 21, 2026 (Robbins Larry, Director).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 21, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Advisors LLC | 86.2 million | 6.75% | $8.1B |
| Vanguard Capital Management LLC | 83.3 million | 6.53% | $7.8B |
| Capital Research & Management Co. (World Investors) | 75.0 million | 5.87% | $7.0B |
| State Street Corporation | 60.3 million | 4.72% | $5.7B |
| Dodge & Cox | 50.0 million | 3.92% | $4.7B |
| Wellington Trust Co., NA | 33.8 million | 2.65% | $3.2B |
| Geode Capital Management LLC | 29.9 million | 2.34% | $2.8B |
| Fidelity Management & Research Co. LLC | 28.9 million | 2.27% | $2.7B |
| Vanguard Portfolio Management LLC | 26.6 million | 2.09% | $2.5B |
| BlackRock Life Ltd. | 25.3 million | 1.99% | $2.4B |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 2,188 | 1.33 billion | $121.0B |
| Q1 2026 | 1,986 | 1.11 billion | $79.4B |
| Q4 2025 | 2,054 | 1.14 billion | $90.0B |
| Q3 2025 | 1,949 | 1.13 billion | $85.2B |
| Q2 2025 | 1,880 | 1.11 billion | $76.3B |
| Q1 2025 | 1,870 | 1.09 billion | $73.6B |
| Q4 2024 | 1,795 | 1.05 billion | $47.2B |
| Q3 2024 | 1,954 | 1.04 billion | $65.4B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Robbins Larry | May 21, 2026 | Director | Sale at price 93.45 - 96.28 per share. | $317.5M |
| Norwalk Leslie V | May 14, 2026 | Director | Stock Award(Grant) at price 97.15 per share. | $140,576 |
| Balser Jeffrey R M.D., Ph.D. | May 14, 2026 | Director | Stock Award(Grant) at price 97.15 per share. | $199,935 |
| Sansone Guy P | May 14, 2026 | Director | Stock Award(Grant) at price 97.15 per share. | $140,576 |
| Aguirre Fernando | May 14, 2026 | Director | Stock Award(Grant) at price 97.15 per share. | $151,845 |
| Brown C David Ii | May 14, 2026 | Director | Stock Award(Grant) at price 97.15 per share. | $150,000 |
| Kirby John Scott | May 14, 2026 | Director | Stock Award(Grant) at price 97.15 per share. | $140,576 |
| Mandadi Tilak | May 8, 2026 | Officer | Sale at price 89.58 per share. | $6.2M |
| Khichi Samrat S | Mar 31, 2026 | General Counsel | Stock Award(Grant) at price 71.82 per share. | $899,976 |
| Capozzi Heidi B | Mar 31, 2026 | Officer | Stock Award(Grant) at price 71.82 per share. | $719,996 |
| Compton-Phillips Amy | Mar 31, 2026 | Officer | Stock Award(Grant) at price 71.82 per share. | $399,966 |
| Newman Brian | Mar 31, 2026 | Chief Financial Officer | Stock Award(Grant) at price 71.82 per share. | $1.4M |
Newest 12 of 66 insider transactions in the last two years.
BlackRock Advisors LLC, with 6.75% of the company (as of September 25, 2026). Next: Vanguard Capital Management LLC (6.53%) and Capital Research & Management Co. (World Investors) (5.87%).
2,188 institutional holdings reports listed CVS Health shares in Q2 2026, 1.33 billion shares in all worth $121.00 billion.
In the last two years insiders reported 5 sales and 3 purchases (66 transactions in all); the newest on file is from May 21, 2026.